Sawgrass Asset Management’s NeoGenomics NEO Stock Holding History

Sawgrass Asset Management’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-4,525	Closed	-$244K	–	182
2020 Q4	$244K	Buy	+4,525	New	+$204K	0.02%	143
2019 Q2	–	Sell	-35,455	Closed	-$725K	–	200
2019 Q1	$725K	Buy	35,455 +17,550	+98%	+$305K	0.03%	130
2018 Q4	$226K	Buy	+17,905	New	+$267K	0.01%	197

Other funds holding NEO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

KFO

Kopp Family Office Bloomington, Minnesota $163M AUM 22.57% 1-Year Est. Return

Sawgrass Asset Management's NEO Position: Q1 2021 in Review

Sawgrass Asset Management sold out of NeoGenomics (NEO) in Q1 2021, closing a stake of 4,525 shares — an estimated $244K sold.

Sawgrass Asset Management first reported a position in NEO in Q4 2018 and held it in 3 quarters. The position peaked at $725K in Q1 2019. 332 funds tracked by Wall St. Rank hold NEO as of Q1 2021.

Sawgrass Asset Management reported no remaining NeoGenomics position as of Q1 2021 after selling out during the quarter.
Sawgrass Asset Management sold 4,525 NeoGenomics shares in Q1 2021, an estimated $244K.
Sawgrass Asset Management first reported a position in NeoGenomics in Q4 2018 and held it in 3 quarters.
Sawgrass Asset Management's NeoGenomics position peaked at $725K in Q1 2019.
332 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2021.

Based on Sawgrass Asset Management's 13F filing for Q1 2021, filed 29 Apr 2021.